Sinclair Enerjet Experience
www.vioramed.comAbout Sinclair Pharma Sinclair Pharma is an international company operating in the fast growth, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies in both the injectable and EDB segments. Both divisions are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. Sinclair is planning entry to multiple new geographic markets and line extension launches over the next few years. The Group has an established sales and marketing presence in the EU markets, Brazil, Mexico, Colombia, UAE, Hong Kong and South Korea and a network of international distributors. For more information, visit www.sinclairpharma.com About Viora Sinclair acquired Viora, a market leader in advanced medical aesthetic research, development and manufacturing in February of 2022; making Viora a cornerstone in the genesis of Sinclair’s Energy Device Division. With a presence in more than 65 countries, Viora’s non-invasive products address a wide range of solutions, treating today’s most commonly requested applications used in anti-aging, body & facial contouring, cellulite reduction, acne clearance, hair removal and more. For more information, visit www.vioramed.com
Read moreAbout Sinclair Pharma Sinclair Pharma is an international company operating in the fast growth, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies in both the injectable and EDB segments. Both divisions are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. Sinclair is planning entry to multiple new geographic markets and line extension launches over the next few years. The Group has an established sales and marketing presence in the EU markets, Brazil, Mexico, Colombia, UAE, Hong Kong and South Korea and a network of international distributors. For more information, visit www.sinclairpharma.com About Viora Sinclair acquired Viora, a market leader in advanced medical aesthetic research, development and manufacturing in February of 2022; making Viora a cornerstone in the genesis of Sinclair’s Energy Device Division. With a presence in more than 65 countries, Viora’s non-invasive products address a wide range of solutions, treating today’s most commonly requested applications used in anti-aging, body & facial contouring, cellulite reduction, acne clearance, hair removal and more. For more information, visit www.vioramed.com
Read moreCountry
City (Headquarters)
London
Industry
Employees
11-50
Founded
2007
Estimated Revenue
$10,000,000 to $50,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
General Manager
Email ****** @****.comPhone (***) ****-****Consultant
Email ****** @****.comPhone (***) ****-****Consultant
Email ****** @****.comPhone (***) ****-****
Technologies
(43)